Preview

Medical Genetics

Advanced search
Open Access Open Access  Restricted Access Subscription Access

Preimplantation genetic testing for mucopolysaccharidosis type II: a case report

https://doi.org/10.25557/2073-7998.2022.10.12-18

Abstract

Aim: description of an assisted reproductive technology (ART) program with preimplantation genetic testing (PGT) for spinocerebellar ataxia type 1 (SCA1) in combination with preimplantation chromosome analysis. Methods. Planning and implementation of PGT was performed for a couple (aged 30 and 31) from Sakha (Yakutia) at risk of SCA1. We have developed PGT system for monogenic diseases (PGT-M), which includes the analysis of the pathogenic variant of the ATXN1 gene (NM_000332.3(ATXN1):c.589_591CAG(36_38) (p.Gln208_His209ins(Gln)n) and polymorphic STR markers linked to the gene. For setup study DNA was isolated from the blood of the patient and partner, the patient’s sister and father, and a healthy unrelated donor. The study was performed by nested PCR with detection by fragment analysis. The developed system was validated on single cell samples. Ovulation stimulation and embryological procedures during the ART program were performed according to standard protocols, fertilization was performed by ICSI. Embryo biopsy was performed on the 5th day of development. Whole genome amplification (WGA) for trophectoderm samples was performed using multiple displacement amplification (MDA). WGA product was used for PGT-M according to the system developed at the setup stage, then for chromosomal microarray analysis of aneuploidy (PGT-A). The cryotransfer was performed taking into account the results of preimplantation testing. Results. The developed PGT-M system included analysis of the ATXN1 gene fragment carrying CAG repeats and analysis of 9 informative STR markers flanking the gene. Five mature oocytes were obtained in the ART program. Three embryos reached the blastocyst stage and were biopsied; WGA and PGT-M were performed for them. The mutant allele was well identified in two embryos. One of the three embryos was determined to be normal for the ATXN1 genotype and maternal STR haplotype. PGT-A was performed for one normal embryo, the result showed a normal chromosomal status. The embryo was transferred into the uterus. The results of hCG (human chorionic gonadotropin) confirmed the implantation of the embryo. Conclusions. Our clinical case demonstrates the successful implementation of the ART program with PGT-M for SCA1 in combination with the analysis of PGT-A.

About the Authors

E. V. Soloveva
Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences
Russian Federation


M. M. Skleimova
Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences
Russian Federation


L. I. Minaycheva
Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences
Russian Federation


D. I. Zhigalina
Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences
Russian Federation


E. O. Churkin
ART Center of the Siberian State Medical University of the Ministry of Health of Russia
Russian Federation


Y. V. Okkel
ART Center of the Siberian State Medical University of the Ministry of Health of Russia
Russian Federation


References

1. Zoghbi H.Y., Orr H.T. Pathogenic Mechanisms of a Polyglutamine-mediated Neurodegenerative Disease, Spinocerebellar Ataxia Type 1. The Journal of Biological Chemistry. 2009;284(12):7425-7429. doi: 10.1074/jbc.R800041200.

2. Воловиков Е.А., Давиденко А.В., Лагарькова М.А. Молекулярные механизмы атаксии первого типа. Генетика. 2020;56(2):127-141. doi: 10.31857/S0016675820020125

3. Фёдоров А.И., Сухомясова А.Л., Голикова П.И. и др. Распространённость спиноцеребеллярной атаксии 1 типа в Якутии: современное состояние. Медицинская генетика. 2020; 56(2): 127-141. doi: 10.25557/2073-7998.2020.07.29-30.

4. Srinivasan S.R., Shakkottai V.G. Moving Towards Therapy in SCA1: Insights from Molecular Mechanisms, Identification of Novel Targets, and Planning for Human Trials. Neurotherapeutics. 2019;16:999-1008. https://doi.org/10.1007/s13311-019-00763-y.

5. Drusedau M., Dreesen J.C.F.M., Die-Smulders C.D. Preimplantation genetic diagnosis of spinocerebellar ataxia 3 by (CAG)(n) repeat detection. Mol Hum Reprod. 2004;10(1):71-5. doi: 10.1093/molehr/gah008.

6. Verlinsky Y., Kuliev A. Atlas of Preimplantation Genetic Diagnosis. Second edition. 2005. Taylor & Francis: 281.

7. Moutou C., Nicod J.C., Gardes N., Viville S. Birth after preimplantation genetic diagnosis (PGD) of spinocerebellar ataxia 2 (SCA2). Prenat Diagn. 2008;28:126-30. doi: 10.1002/pd.1909.

8. Tur-Kaspa I., Jeelani R., Doraiswamy P.M. Preimplantation genetic diagnosis for inherited neurological disorders. Nat Rev Neurol. 2014;10(7):417-24. doi:10.1038/nrneurol.2014.84.

9. Liao C.H., Chang M.Y., Ma G.C. et al. Preimplantation Genetic Diagnosis of Neurodegenerative Diseases: Review of Methodologies and Report of Our Experience as a Regional Reference Laboratory. Diagnostics. 2019;9:44. doi:10.3390/diagnostics9020044.

10. Shi D., Xu J., Niu W., et al. Live births following preimplantation genetic testing for dynamic mutation diseases by karyomapping: a report of three cases. Journal of Assisted Reproduction and Genetics. 2020;37:539-548. https://doi.org/10.1007/s10815-020-01718-5.

11. Cahn S., Rosen A., Wilmot G. Spinocerebellar Ataxia Patient Perceptions Regarding Reproductive Options. Movement Disorders Clinical Practice. 2020;7(1):37-44. doi: 10.1002/mdc3.12859.

12. Ethics Committee of the American Society for Reproductive Medicine. Use of preimplantation genetic testing for monogenic defects (PGT-M) for adult-onset conditions: an Ethics Committee opinion. Fertility and Sterility. 2018;109(6):989-992. https://doi.org/10.1016/j.fertnstert.2018.04.003.

13. Вспомогательные репродуктивные технологии и искусственная инсеминация. Клинические рекомендации (протокол лечения). МЗ РФ 05 марта 2019 года № 15-4/и/2-1908. 169 с. http://www.rahr.ru/pech_mat_norm.php.

14. ESHRE PGT Consortium and SIG-Embryology BiopsyWorking Group, Kokkali G, Coticchio G. et al. ESHRE PGT Consortium and SIG Embryology good practice recommendations for polar body and embryo biopsy for PGT. Human Reproduction Open. 2020:1-12. doi:10.1093/hropen/hoaa020.

15. ESHRE PGT-M Working Group, Carvalho F, Moutou C, et al. ESHRE PGT Consortium good practice recommendations for the detection of monogenic disorders Human Reproduction Open. 2020:1-18. doi:10.1093/hropen/hoaa018.

16. ESHRE PGT-SR/PGT-A Working Group, Coonen E, Rubio C. et al. ESHRE PGT Consortium good practice recommendations for the detection of structural and numerical chromosomal aberrations. Human Reproduction Open. 2020: Human Reproduction Open, pp. 1-20, 2020. doi:10.1093/hropen/hoaa017.

17. Sequeiros J., Seneca S., Martindale J. Consensus and controversies in best practices for molecular genetic testing of spinocerebellar ataxias. European Journal of Human Genetics. 2010;18:1188-1195. doi:10.1038/ejhg.2010.10.


Review

For citations:


Soloveva E.V., Skleimova M.M., Minaycheva L.I., Zhigalina D.I., Churkin E.O., Okkel Y.V. Preimplantation genetic testing for mucopolysaccharidosis type II: a case report. Medical Genetics. 2022;21(10):12-18. (In Russ.) https://doi.org/10.25557/2073-7998.2022.10.12-18

Views: 328


ISSN 2073-7998 (Print)